More TrivarX Limited news
TrivarX LimitedASX: TRI

Sleep Analysis Depressive Burden Study Clinical Trial

Jul 20, 2022 at 11:39 PM EDT · Issued by TrivarX Limited

Filed with ASX · Jul 20, 2022 at 11:39 PM EDT

On 6ix: 6ix.com/news/sleep-analysis-depressive-burden-study-clinical-trial

Trivarx Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

TrivarX Limited on 6ix

Story so far

  • MEB Signs Clinical Trial Agreement with MedBridge HealthcareOct 7, 2020

Earlier from TrivarX

  • MEB to Raise $1.4m by way of a Placement & MD/CEO ResignsJun 22, 2022
  • Reinstatement to QuotationJun 22, 2022
  • Voluntary SuspensionJun 16, 2022
  • FDA Confirm Diagnostic Method on Depression Validation TrialMay 18, 2022
  • Medibio Announces Entitlement Offer ResultMar 10, 2022

Later from TrivarX

  • Appendix 4E and Preliminary Final ReportAug 31, 2022
  • Medibio Appoints CEOSep 19, 2022
  • Medibio Receives R&D Tax Incentive RefundNov 14, 2022
  • Medibio Quarterly Update and Cashflow ReportJan 30, 2023
  • MEB to Raise up to $2.75 million By Way of a Placement & SPPFeb 14, 2023
All TrivarX news releases↗

Follow TrivarX into a list and get an email when it puts out news.

Follow TrivarX
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer